Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Gilead Sciences, Inc
NASDAQ:GILD
Gilead Sciences, Inc
NASDAQ:GILD
Price:
174.7
USD
4.32%
Market Closed
Market Cap:
$216.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Gilead Sciences, Inc
NASDAQ:GILD
|
US |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
E
|
Experian PLC
DUS:J2B
|
IE |
|
E
|
Ecoplastic Corp
KOSDAQ:038110
|
KR |
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
M
|
Mirae Asset Vision Special Purpose Acquisition 7 Co
KOSDAQ:482680
|
KR |
|
E
|
EQT Corp
F:EQ6
|
US |
|
CH Robinson Worldwide Inc
NASDAQ:CHRW
|
US |
|
DFI Retail Group Holdings Ltd
SGX:D01
|
HK |
|
Stellantis NV
MIL:STLAM
|
NL |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
EPR Properties
NYSE:EPR
|
US |
Wall St Price Targets
GILD Price Forecast
Based on 31 analysts
Based on 31 analysts
+2% Upside
from
$174.7
today
Gilead Sciences, Inc (GILD)’s 12-month stock price forecast through November 2027 has a consensus target of $178.5, implying 2% upside. The forecast is based on price targets from 31 Wall Street analysts.
GILD Analyst Rating
Based on 28 analysts
Based on 28 analysts
Analysts rate GILD Buy, with 22 of 28 recommending Buy or Strong buy.
Gilead Sciences, Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GILD's stock price target?
Price Target
178.5
USD
178.5
USD
According to Wall Street analysts, the average 1-year price target for GILD is 178.5 USD with a low forecast of 132.31 USD and a high forecast of 210 USD.
What is the Revenue forecast for Gilead Sciences, Inc?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences, Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences, Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences, Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Gilead Sciences, Inc?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 10%.
